BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir
BPR3P0128 是一种非核苷类 RNA 依赖性 RNA 聚合酶抑制剂，可抑制令人担忧的 SARS-CoV-2 变体，并与瑞德西韦联合发挥协同抗病毒作用
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.1
doi:10.1128/aac.00956-23
Wen-Fang Tang #, Yu-Hsiu Chang #, Cheng-Chin Lin #, Jia-Rong Jheng #, Chung-Fan Hsieh #, Yuan-Fan Chin #, Tein-Yao Chang #, Jin-Ching Lee #, Po-Huang Liang #, Chia-Yi Lin, Guan-Hua Lin, Jie-Yun Cai, Yu-Li Chen, Yuan-Siao Chen, Shan-Ko Tsai, Ping-Cheng Liu, Chuen-Mi Yang, Tolou Shadbahr, Jing Tang, Y
